Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01614106 · ClinicalTrials.gov registry record · NA
Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 360
- Enrollment target
NCT01614106 is a NA study that has completed, run by Columbia University. The registered enrollment target is 360 participants.
The verdict
NCT01614106, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 360 participants
- Enrollment target
Study Summary
This study will evaluate the efficacy of an integrated "Retention Clinic" in achieving virologic suppression among HIV-infected cocaine (including crack) users by using a two-group randomized, prospective trial. A total of 360 HIV-infected individuals who report cocaine (including crack) use will be randomized across study sites. The primary hypothesis is that more participants randomized to the "Retention Clinic" will have undetectable viral load than will participants randomized to the treatment as usual group.
Interventions
- BEHAVIORAL Retention Clinic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2013-01 |
| Est. Completion | 2021-03-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01614106
The ClinicalTrials.gov registry entry for NCT01614106 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Retention Clinic is the first listed.
NCT01614106 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01614106 about?
NCT01614106 is a clinical study titled "Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users". This study will evaluate the efficacy of an integrated "Retention Clinic" in achieving virologic suppression among HIV-infected cocaine (including crack) users by using a two-group randomized, prospective trial. A total of 360 HIV-infected individuals who report cocaine (including crack) use will be...
What is the current status of trial NCT01614106?
This trial is currently completed. It is a NA study. The enrollment target is 360 participants. The study started on 2013-01. Estimated completion is 2021-03-12.
What interventions are being tested in trial NCT01614106?
The interventions under investigation include: Retention Clinic (BEHAVIORAL).
Who is sponsoring clinical trial NCT01614106?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.